SHANGHAI, TAIPEI and SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, and WuXi Biologics (2269.HK), a leading global Contract Research,...
Hence then, the article about hanchorbio and wuxi biologics enter strategic partnership to advance next generation bi and multi functional fusion protein pipeline was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline )
Also on site :
- 2007 Career-Defining Hit, Inspired by a Reba McEntire Song, Is Still a Powerful Masterpiece 19 Years Later
- 31 Years Ago, Sandra Bullock Made History With the First-Ever Online Movie Ticket Purchase — The Nostalgic Video Going Viral
- Iran destroys US spy Saildrone in Hormuz (VIDEO)